Inhibrx Biosciences
INBX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Inhibrx Biosciences(INBX) predict that the EBIT is -30.93 M (+27.91%), Miss estimate;the EPS is -2.15 (+23.21%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.03B27.91%
-0.03B36.84%
-0.00B8.93%
EPSMiss expectations
-2.1523.21%
-1.78536.25%
-0.365013.04%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf